Min Xu

发表

Dysfunction of Prohibitin 2 Results in Reduced Susceptibility to Multiple Antifungal Drugs via Activation of the Oxidative Stress-Responsive Transcription Factor Pap1 in Fission Yeast

T. Kuno, Yue Fang, Qiannan Liu, 2018, Antimicrobial Agents and Chemotherapy.

Investigate Natural Product Indolmycin and the Synthetically Improved Analogue Toward Antimycobacterial Agents.

Yefeng Tang, Y. Yue, Shawn Chen, 2021, ACS chemical biology.

Rediscovery of PF-3845 as a new chemical scaffold inhibiting phenylalanyl-tRNA synthetase in Mycobacterium tuberculosis

D. Schnappinger, Lan Xu, S. Fan, 2021, The Journal of biological chemistry.

Rediscovery of PF-3845 as a new chemical scaffold inhibiting phenylalanyl-tRNA synthetase in Mycobacterium tuberculosis

D. Schnappinger, Lan Xu, S. Fan, 2020, bioRxiv.

Phylogeny-Informed Synthetic Biology Reveals Unprecedented Structural Novelty in Type V Glycopeptide Antibiotics

G. Wright, Nicholas Waglechner, Wenliang Wang, 2022, ACS central science.

GPAHex-A synthetic biology platform for Type IV–V glycopeptide antibiotic production and discovery

Gerard D. Wright, Nicholas Waglechner, Wenliang Wang, 2020, Nature Communications.

A non-reactive natural product precursor of the duocarmycin family has potent and selective antimalarial activity.

T. Gilberger, Michael A. Cook, Gerard D. Wright, 2021, Cell chemical biology.

Heterologous expression-facilitated natural products’ discovery in actinomycetes

Gerard D. Wright, Min Xu, 2019, Journal of Industrial Microbiology & Biotechnology.

Synthetic Biology Facilitates Semisynthetic Development of Type V Glycopeptide Antibiotics Targeting Vancomycin-Resistant Enterococcus.

Gerard D. Wright, K. Koteva, Aline A. Fiebig-Comyn, 2023, Journal of medicinal chemistry.